The pros and cons of pooling supplies for clinical trials
Pooling drug products in clinical trials sounds like an easy way to reduce waste and cut costs. So why don’t more sponsors do it?
Sharp Clinical
Analytical testing: Ten questions that accelerate drug development
Delivering the direct-to-patient promise: Are regulatory and tech challenges standing in the way?
Why demand is rising for secure and climate-controlled gene therapy services
Sustainable supply chains: clinical trials in a new era of limited resources
